These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 25879228)

  • 1. Can red yeast rice and olive extract improve lipid profile and cardiovascular risk in metabolic syndrome?: A double blind, placebo controlled randomized trial.
    Verhoeven V; Van der Auwera A; Van Gaal L; Remmen R; Apers S; Stalpaert M; Wens J; Hermans N
    BMC Complement Altern Med; 2015 Mar; 15():52. PubMed ID: 25879228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A red yeast rice-olive extract supplement reduces biomarkers of oxidative stress, OxLDL and Lp-PLA
    Hermans N; Van der Auwera A; Breynaert A; Verlaet A; De Bruyne T; Van Gaal L; Pieters L; Verhoeven V
    Trials; 2017 Jul; 18(1):302. PubMed ID: 28673363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of a combination of red yeast rice and olive extract in hypercholesterolemic patients with and without statin-associated myalgia.
    Tshongo Muhindo C; Ahn SA; Rousseau MF; Dierckxsens Y; Hermans MP
    Complement Ther Med; 2017 Dec; 35():140-144. PubMed ID: 29154060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Red yeast rice lowers cholesterol in physicians - a double blind, placebo controlled randomized trial.
    Verhoeven V; Lopez Hartmann M; Remmen R; Wens J; Apers S; Van Royen P
    BMC Complement Altern Med; 2013 Jul; 13():178. PubMed ID: 23866314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of low molecular weight procyanidin rich extract from french maritime pine bark on cardiovascular disease risk factors in stage-1 hypertensive subjects: Randomized, double-blind, crossover, placebo-controlled intervention trial.
    Valls RM; Llauradó E; Fernández-Castillejo S; Puiggrós F; Solà R; Arola L; Pedret A
    Phytomedicine; 2016 Nov; 23(12):1451-1461. PubMed ID: 27765365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pitavastatin: novel effects on lipid parameters.
    Chapman MJ
    Atheroscler Suppl; 2011 Nov; 12(3):277-84. PubMed ID: 22152282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Red yeast rice improves lipid pattern, high-sensitivity C-reactive protein, and vascular remodeling parameters in moderately hypercholesterolemic Italian subjects.
    Cicero AF; Derosa G; Parini A; Maffioli P; D'Addato S; Reggi A; Giovannini M; Borghi C
    Nutr Res; 2013 Aug; 33(8):622-8. PubMed ID: 23890351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Extended-Release Niacin on High-Density Lipoprotein (HDL) Functionality, Lipoprotein Metabolism, and Mediators of Vascular Inflammation in Statin-Treated Patients.
    Yadav R; Liu Y; Kwok S; Hama S; France M; Eatough R; Pemberton P; Schofield J; Siahmansur TJ; Malik R; Ammori BA; Issa B; Younis N; Donn R; Stevens A; Durrington P; Soran H
    J Am Heart Assoc; 2015 Sep; 4(9):e001508. PubMed ID: 26374297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of rosuvastatin and atorvastatin on LDL and HDL particle concentrations in patients with metabolic syndrome: a randomized, double-blind, controlled study.
    Rosenson RS; Otvos JD; Hsia J
    Diabetes Care; 2009 Jun; 32(6):1087-91. PubMed ID: 19265025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the Effects of Cucumis sativus Seed Extract on Serum Lipids in Adult Hyperlipidemic Patients: A Randomized Double-Blind Placebo-Controlled Clinical Trial.
    Soltani R; Hashemi M; Farazmand A; Asghari G; Heshmat-Ghahdarijani K; Kharazmkia A; Ghanadian SM
    J Food Sci; 2017 Jan; 82(1):214-218. PubMed ID: 27886382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Randomized, Double-Blinded, Placebo-Controlled, Clinical Study of the Effects of a Nutraceutical Combination (LEVELIP DUO
    Cicero AFG; D'Addato S; Borghi C
    Nutrients; 2020 Oct; 12(10):. PubMed ID: 33066334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the effects of a standardized aqueous extract of Phyllanthus emblica fruits on endothelial dysfunction, oxidative stress, systemic inflammation and lipid profile in subjects with metabolic syndrome: a randomised, double blind, placebo controlled clinical study.
    Usharani P; Merugu PL; Nutalapati C
    BMC Complement Altern Med; 2019 May; 19(1):97. PubMed ID: 31060549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of ezetimibe added to on-going statin therapy on the lipid profile of hypercholesterolemic patients with diabetes mellitus or metabolic syndrome.
    Simons L; Tonkon M; Masana L; Maccubbin D; Shah A; Lee M; Gumbiner B
    Curr Med Res Opin; 2004 Sep; 20(9):1437-45. PubMed ID: 15383192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Curcuminoids modify lipid profile in type 2 diabetes mellitus: A randomized controlled trial.
    Panahi Y; Khalili N; Sahebi E; Namazi S; Reiner Ž; Majeed M; Sahebkar A
    Complement Ther Med; 2017 Aug; 33():1-5. PubMed ID: 28735818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pitavastatin in cardiometabolic disease: therapeutic profile.
    Masana L
    Cardiovasc Diabetol; 2013; 12 Suppl 1(Suppl 1):S2. PubMed ID: 23819752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of a new combination of nutraceuticals with Morus alba on lipid profile, insulin sensitivity and endotelial function in dyslipidemic subjects. A cross-over, randomized, double-blind trial.
    Trimarco V; Izzo R; Stabile E; Rozza F; Santoro M; Manzi MV; Serino F; Schiattarella GG; Esposito G; Trimarco B
    High Blood Press Cardiovasc Prev; 2015 Jun; 22(2):149-54. PubMed ID: 25870124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of alirocumab on lipids and lipoproteins in individuals with metabolic syndrome without diabetes: Pooled data from 10 phase 3 trials.
    Henry RR; Müller-Wieland D; Taub PR; Bujas-Bobanovic M; Louie MJ; Letierce A; Ginsberg HN
    Diabetes Obes Metab; 2018 Jul; 20(7):1632-1641. PubMed ID: 29493859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Bempedoic Acid vs Placebo Added to Maximally Tolerated Statins on Low-Density Lipoprotein Cholesterol in Patients at High Risk for Cardiovascular Disease: The CLEAR Wisdom Randomized Clinical Trial.
    Goldberg AC; Leiter LA; Stroes ESG; Baum SJ; Hanselman JC; Bloedon LT; Lalwani ND; Patel PM; Zhao X; Duell PB
    JAMA; 2019 Nov; 322(18):1780-1788. PubMed ID: 31714986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A double-blind, double-dummy, randomized, placebo-controlled trial to evaluate the effect of statin therapy on triglyceride levels in Mexican hypertriglyceridemic patients.
    Talavera JO; Martinez G; Cervantes JL; Marin JA; Rodriguez-Briones I; Gonzalez JG; Ocampo R; Sanchez-Mijangos H; Bernal-Rosales LP; Polanco A
    Curr Med Res Opin; 2013 Apr; 29(4):379-86. PubMed ID: 23323877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Red yeast rice for dyslipidemia in statin-intolerant patients: a randomized trial.
    Becker DJ; Gordon RY; Halbert SC; French B; Morris PB; Rader DJ
    Ann Intern Med; 2009 Jun; 150(12):830-9, W147-9. PubMed ID: 19528562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.